Bone Anchored Hearing Aids Global Market to Reach $403 Million by 2027 at a CAGR of 8.36% - ResearchAndMarkets.com

2022-12-09
DUBLIN--(BUSINESS WIRE)--The "Bone Anchored Hearing Aids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
'Bone Anchored Hearing Aids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027'
The global bone anchored hearing aids market size reached US$ 249 Million in 2021. Looking forward, the publisher expects the market to reach US$ 403 Million by 2027, exhibiting a CAGR of 8.36% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A bone anchored hearing aid (BAHA) is a surgical, implantable device used to treat individuals with different types of hearing loss. It has a titanium screw anchored to the mastoid bone behind the ear, which is connected to a small detachable sound processor through an abutment that propagates sound directly to the inner ear, bypassing skin impedance and subcutaneous tissues. It provides better sound quality and greater comfort compared to conventional hearing devices. Compared to the BTE (behind-the-ear hearing aids), it does not cause skin irritation, requires less energy, reduces aural discharge, and is gaining traction worldwide among children and adults with single-sided deafness and conductive or mixed hearing loss.
As the risk of developing hearing impairment increases with age, the rising geriatric population represents one of the key factors bolstering the market growth. Moreover, the growing instances of hearing loss in pediatrics, along with the high risk of surgery, are escalating the demand for soft band BAHA that acts as a non-surgical solution for a limited period.
Additionally, governing agencies of several countries are implementing rules and regulations that require neonates to be screened for hearing loss. This trend, along with the availability of better reimbursement coverage, is impacting the market growth positively. Apart from this, robotic platforms and surgical navigation systems are gaining popularity around the world to reduce BAHA surgical complications. The market players are also introducing advanced products to expand their consumer base. For instance, MED-EL, a company that manufactures hearing implants, launched ADHEAR. This non-implanted BAHA device is suitable for all ages and provides effortless hearing and reliable listening.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global bone anchored hearing aids market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on raw material, hearing loss type and end user.
Breakup by Raw Material:
Titanium Alloy
Ceramics Composites
Others
Breakup by Hearing Loss Type:
Mixed Hearing Loss
Single Sided Deafness
Breakup by End User:
Pediatrics
Adults
Geriatrics
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
5 Global Bone Anchored Hearing Aids Market
6 Market Breakup by Raw Material
7 Market Breakup by Hearing Loss Type
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
Companies Mentioned
Auditdata A/S
For more information about this report visit https://www.researchandmarkets.com/r/zdxhiv
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。